The clinical story began with what seemed, at first, to be a routine neonatal complaint. According to the case report, the infant had shown skin jaundice for two days before admission, and in the three hours before she was brought to the hospital she had decreased her milk intake and cried persistently. These are among the most common reasons newborns are evaluated by pediatricians, and none of them points specifically toward sepsis. That ambiguity is precisely what makes the case instructive, the authors argue: neonatal Edwardsiella tarda septicemia presents with non-specific clinical manifestations, which makes early diagnosis exceptionally challenging. A delayed or missed diagnosis of bacterial sepsis in a newborn can be fatal, so the stakes of recognizing unusual pathogens are high.

Blood culture provided the decisive answer. Culturing the infant’s blood allowed the laboratory to identify Edwardsiella tarda as the organism circulating in her bloodstream, confirming the diagnosis of neonatal septicemia. Blood culture remains the diagnostic gold standard for neonatal sepsis, because the clinical signs of infection in newborns, from temperature instability to poor feeding and lethargy, overlap so heavily with other neonatal illnesses that laboratory confirmation is essential before targeted therapy can be chosen. In this case, the identification of an organism that most pediatricians will never encounter in a newborn blood culture immediately placed the infant’s care in uncommon territory.

Edwardsiella tarda is a Gram-negative bacterium in the family Enterobacteriaceae, and its natural history is dominated by aquatic environments and cold-blooded animals. It is a well-documented pathogen of fish, causing disease in farmed and wild species, and it can also colonize reptiles and amphibians. Human infections are uncommon and typically occur through exposure to contaminated water or aquatic food sources, most often producing gastrointestinal illness. When the bacterium does invade the bloodstream, the consequences can be severe; the authors note that Edwardsiella tarda bacteremia can be a fatal disease in humans. Its appearance in the blood of a five-day-old infant is an event rare enough that the Jiangyou team combined their case with a review of the published literature to map what is known about this infection in newborns.

One of the most striking elements of the case involved a finding that extended beyond the bloodstream infection itself. During hospitalization, the infant was found to have a subgaleal hematoma over the left parietal region of her skull, a collection of blood between the scalp and the skull covering that had been present on imaging. That hematoma progressed to abscess rupture during her hospital stay, meaning the blood collection became infected and broke down. A subgaleal abscess in a newborn represents a serious complication, because the potential space between the galea aponeurotica and the skull can allow blood and pus to spread widely across the scalp, and infection in this compartment can seed the underlying structures. The progression of a sterile hematoma into an abscess in the setting of bacteremia illustrates how a circulating infection and a local collection of blood can reinforce one another, with bacteria seeding the hematoma and the hematoma providing a protected environment in which the bacteria can proliferate beyond the reach of circulating antibiotics.

Treatment combined two complementary strategies. The infant received meropenem, a broad-spectrum carbapenem antibiotic active against many Gram-negative organisms, including Enterobacteriaceae such as Edwardsiella tarda. Carbapenems are typically reserved for severe infections or for situations in which resistance to narrower agents is a concern, and their use here reflects the gravity of neonatal septicemia and the need to achieve rapid, reliable bacterial killing. Alongside the antibiotic, the clinicians administered adjunctive intravenous immunoglobulin, or IVIG, a blood-derived product concentrated with antibodies that can support the immature immune system of a newborn. Neonates have limited capacity to produce their own antibodies and to opsonize encapsulated and Gram-negative bacteria effectively, and IVIG is sometimes used as adjunctive therapy in severe neonatal sepsis to supplement the infant’s antibody repertoire while antibiotics address the underlying infection.

Supportive care completed the therapeutic picture. Newborns with septicemia require meticulous management of fluid balance, nutrition, temperature, and organ function, because the physiological reserves of a five-day-old are minimal and the systemic inflammatory response to bacterial sepsis can rapidly destabilize multiple organ systems. In this infant, the combination of meropenem, IVIG, and supportive measures succeeded in clearing the infection and resolving the local complication. The subgaleal abscess, despite its rupture during hospitalization, did not prevent a full recovery, and the authors report that the infant was discharged without long-term complications, an outcome that stands in welcome contrast to the potentially fatal trajectory of untreated Edwardsiella tarda bacteremia.

The rarity of this infection in newborns is what gives the case report its scientific value. By pairing their single case with a literature review, the authors have assembled a reference point for clinicians who may encounter similar presentations. The published record of Edwardsiella tarda infections in neonates is sparse, and each documented case contributes to a collective understanding of how the infection is acquired, how it manifests, and how it responds to treatment. The authors emphasize that awareness of potential environmental or aquatic exposures may be helpful when considering Edwardsiella tarda infection in neonates, a recommendation that reflects the bacterium’s ecology. In practice, this means that when a newborn presents with sepsis and cultures yield an unexpected aquatic-associated organism, clinicians should think to ask about the environments the mother and infant have contacted, from household water sources to contact with fish or aquatic animals.

The case also highlights the role of maternal exposure in the chain of transmission. The article’s keywords include maternal exposure, underscoring the authors’ interest in how a newborn so young, with no independent contact with the outside world beyond the delivery environment, could acquire a bacterium associated with water and aquatic animals. Possible routes in such cases include contamination during labor and delivery, contact in the home environment after discharge, or transmission from a colonized mother. The report does not resolve this question definitively for this infant, but by flagging maternal and environmental exposure as a consideration, it gives pediatricians a concrete line of inquiry when the unusual diagnosis arises.

For the wider medical community, the takeaways are practical. First, neonatal sepsis remains a diagnosis in which the clinical picture can deceive: jaundice and poor feeding, two of the most ordinary findings in a newborn, were the opening signs of a life-threatening bloodstream infection. Second, blood cultures must be obtained promptly whenever sepsis is suspected, because identifying the organism is the only way to move from empiric coverage to targeted therapy, particularly when the pathogen involved is as unusual as Edwardsiella tarda. Third, unusual organisms demand unusual histories, and asking about aquatic and environmental exposures can illuminate infections that would otherwise remain unexplained. Finally, the case demonstrates that even a rare and potentially fatal neonatal infection can have a good outcome when it is diagnosed by culture, treated with appropriate broad-spectrum antibiotics and adjunctive immunotherapy, and monitored closely for local complications such as the infected subgaleal hematoma that complicated this infant’s course. The authors, Qinnan Shao, Haixia Xie, Haixia Liu, and Hong Lin, all of the Department of Pediatrics at Jiangyou People’s Hospital, published the case as an open-access report so that clinicians elsewhere can draw on the experience when the same rare pathogen next appears in a newborn’s blood culture.

Subject of Research: Neonatal septicemia caused by Edwardsiella tarda

Article Title: Neonatal septicemia caused by Edwardsiella tarda: a case report and literature review

Article References: Shao, Q., Xie, H., Liu, H., & Lin, H. (2026). Neonatal septicemia caused by Edwardsiella tarda: a case report and literature review. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07819-x

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07819-x

Keywords: Edwardsiella tarda, neonatal sepsis, bloodstream infection, blood culture, meropenem, intravenous immunoglobulin, subgaleal hematoma, abscess, aquatic exposure, maternal exposure, neonatology, bacterial infection

Viridans group streptococci are a large collection of related bacterial species that normally live harmlessly in the human mouth, throat, gastrointestinal tract, and genitourinary tract. Unlike their more notorious cousins, Streptococcus pneumoniae or Streptococcus pyogenes, they are typically regarded as low-virulence organisms, so much so that when they appear in a blood culture, clinicians sometimes dismiss the result as contamination from skin flora. Yet these bacteria possess a darker side. They can adhere to damaged or artificial heart valves, form vegetations, and cause infective endocarditis, a life-threatening infection of the heart’s inner lining. They can also travel through the circulation to distant organs and establish metastatic pockets of pus, including abscesses in the abdomen, brain, liver, or deep tissues of the neck. Distinguishing between a transient, benign shower of bacteria and the beginning of a truly invasive infection is one of the persistent diagnostic dilemmas in infectious disease medicine.

The new research, published in BMC Infectious Diseases, set out to resolve that dilemma by identifying which factors, measurable at the bedside, predict when viridans group streptococcal bacteremia will turn complicated. The team conducted a single-center retrospective cohort study at Saga University Hospital, reviewing the records of all adults aged eighteen or older from whom viridans group streptococci were isolated from blood cultures between September 2014 and June 2025. To keep the analysis clean, the investigators excluded patients whose blood cultures grew multiple bacterial species, those who arrived in cardiopulmonary arrest, cases judged to be contamination, and patients transferred from other hospitals whose prior course could not be reliably reconstructed.

The definition of a complicated infection was deliberately strict. Patients were classified as complicated only if they had infective endocarditis or a metastatic pyogenic infection, meaning a pus-forming lesion at a sterile body site other than the blood from which viridans group streptococci were also recovered. This distinction matters because it separates genuine deep-tissue invasion from mere presence of bacteria in the bloodstream. Using multivariable logistic regression, a statistical technique that adjusts for the influence of multiple variables simultaneously, the researchers then identified which patient characteristics independently predicted complicated disease.

The results were striking. Among the 164 patients included in the final cohort, 54, or 33 percent, developed complicated infections. Infective endocarditis was the most frequent complication, accounting for 41 percent of complicated cases, followed by intra-abdominal abscess or peritonitis at 22 percent and deep neck infection at 15 percent. These are not trivial diagnoses. Endocarditis often requires prolonged intravenous antibiotic therapy and sometimes cardiac surgery, while deep neck infections can compromise the airway and demand urgent surgical drainage. The fact that a third of all patients with this supposedly mild bacteremia experienced such outcomes challenges the casual attitude many clinicians take toward viridans streptococci in blood cultures.

Perhaps the most counterintuitive finding concerned mortality. In-hospital death occurred in zero percent of patients with complicated infections compared with five percent of those with uncomplicated bacteremia, a difference that did not reach statistical significance. The authors’ data suggest that complicated infections, while more severe in anatomical extent, were recognized and treated, whereas uncomplicated bacteremia may have included patients with greater underlying frailty. The inflammatory markers told a more expected story: white blood cell counts and C-reactive protein levels were both significantly higher in patients with complicated disease, with white cell counts showing a p-value below 0.0001 and C-reactive protein a p-value of 0.0005. Median age, by contrast, was nearly identical between the two groups, at 68 years for complicated cases and 70 years for uncomplicated ones, indicating that age alone offers clinicians little guidance.

The heart of the study lies in its multivariable analysis, which isolated three independent predictors of complicated infection. Community-acquired bacteremia carried an adjusted odds ratio of 4.89, meaning patients who acquired the infection outside the hospital had nearly five times the odds of developing complications compared with those whose bacteremia was hospital-associated. An odontogenic source, meaning the infection originated in the teeth or surrounding dental structures, carried an adjusted odds ratio of 3.07. And bacteremia caused by the Streptococcus anginosus group, a subset of viridans streptococci infamous for forming abscesses, carried an adjusted odds ratio of 2.87. All three confidence intervals excluded one, indicating the associations were statistically robust rather than products of chance.

Each of these predictors tells a coherent biological story. Community acquisition suggests that infections arising from endogenous reservoirs, particularly the mouth, behave differently from hospital-acquired bloodstream infections, which more often reflect indwelling devices or weakened host defenses. The odontogenic association underscores the central role of oral health: dental caries, periodontal disease, and dental procedures can all breach the mucosal barrier and release oral streptococci into the venous circulation. The Streptococcus anginosus group, which includes Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius, is well known among microbiologists for its capacity to produce abscesses, aided by its production of enzymes and its preference for anaerobic, tissue-damaging environments. When these organisms appear in the blood, they frequently signal that a deep-seated collection of pus already exists somewhere in the body.

The clinical implications of the study are practical and immediate. The authors conclude that community acquisition and S. anginosus group bacteremia should raise suspicion for an odontogenic source, prompting clinicians to pursue early imaging, such as computed tomography of the chest, abdomen, or neck depending on symptoms, and to involve dental specialists promptly. Timely source control, whether through drainage of an abscess, extraction of an infected tooth, or debridement of infected tissue, is a cornerstone of managing complicated bacterial infections, and delays in identifying the source are a well-recognized cause of treatment failure. For patients found to have viridans streptococci in their blood, a careful dental examination may be as important as any antibiotic choice.

Beyond the individual bedside, the findings carry a broader public health message about the systemic consequences of neglected oral disease. The mouth is home to one of the densest microbial communities in the human body, and the boundary between commensal colonization and invasive disease is thinner than commonly appreciated. This study, conducted over nearly eleven years at a single Japanese academic center, adds to a growing body of evidence linking oral health to cardiovascular, metabolic, and infectious outcomes elsewhere in the body. While retrospective single-center designs have inherent limitations, including reliance on documentation practices and the referral patterns of one institution, the consistency and strength of the associations reported here give them credibility. For clinicians, the takeaway is to treat viridans group streptococcal bacteremia with appropriate seriousness, particularly when the patient acquired the infection in the community, the organism belongs to the anginosus group, or no obvious source is apparent. For everyone else, the message is older and simpler: the health of your teeth and gums is not separate from the health of the rest of your body, and the bacteria in an abscessed tooth are only a bloodstream away from the heart.

Subject of Research: Risk factors for complicated viridans group streptococcal bacteremia and the role of odontogenic infection sources in adults

Article Title: Factors associated with complicated viridans group streptococcal bacteremia in adults: impact of oral health

Article References: Minami, K., Matono, T., Oka, Y., Urakami, T., & Aoki, Y. (2026). Factors associated with complicated viridans group streptococcal bacteremia in adults: impact of oral health. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14603-w

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14603-w

Keywords: viridans group streptococci, bacteremia, infective endocarditis, odontogenic infection, Streptococcus anginosus group, oral health, abscess, retrospective cohort study, source control, bloodstream infection, infectious diseases, dental caries

The research, conducted at Loghman Hakim Hospital, a tertiary referral centre affiliated with Shahid Beheshti University of Medical Sciences in Tehran, was published in Health Science Reports. It followed the Standards for Reporting of Diagnostic Accuracy Studies (STARD 2015) and enrolled 127 adults with diabetes and clinically suspected foot infection, each of whom underwent both ultrasound and magnetic resonance imaging (MRI) as part of routine care. The stakes are considerable: diabetic foot ulcers affect an estimated 19 to 34 percent of diabetic patients over their lifetime, and people with these ulcers face roughly an eight-fold higher risk of lower extremity amputation compared with non-diabetics. Osteomyelitis is present in 10 to 15 percent of moderate infections and in about half of severe ones, making early and reliable detection a decisive factor in whether a limb is saved.

The technical logic of the study is straightforward but demanding. MRI, performed on a 1.5 Tesla scanner with a full protocol of T1-weighted, T2-weighted, proton-density fat-saturated, diffusion-weighted and contrast-enhanced sequences, served as the reference standard for osteomyelitis and deep abscess, in line with Infectious Diseases Society of America and International Working Group on the Diabetic Foot guidance. On MRI, osteomyelitis was defined by bone marrow oedema appearing dark on T1-weighted images and bright on fluid-sensitive sequences, restricted diffusion, and cortical destruction adjacent to the ulcer. Ultrasound criteria included periosteal elevation or thickening, subperiosteal abscess, and cortical erosion with fluid in direct contact with bone. Ultrasound was always performed first, and each modality was interpreted by a different experienced radiologist blinded to the other’s findings, preserving the independence of the two readings.

The headline result is stark. MRI identified osteomyelitis in 106 of the 127 participants, or 83.5 percent, yet ultrasound detected only 17.9 percent of those MRI-positive cases, with a confidence interval of 11.2 to 26.6 percent. In other words, more than four out of five bone infections visible on MRI were invisible to ultrasound. Specificity was high, at 95.2 percent, meaning that when ultrasound did suggest bone infection it was usually right, with a positive predictive value of 95 percent. But the negative predictive value collapsed to just 18.7 percent overall, and in severe ulcers it fell to an almost meaningless 1.1 percent. A clean ultrasound scan in a severely affected foot, the data show, provides almost no reassurance whatsoever that the underlying bone is healthy.

The severity subgroup analysis sharpens the clinical message. Among the 19 patients with moderate ulcers, classified as Wagner grades 1 and 2, MRI found no osteomyelitis at all, and ultrasound correctly agreed in every case. But among the 108 patients with severe ulcers, grades 3 through 5, MRI confirmed bone infection in 98.1 percent, and ultrasound missed the overwhelming majority of them. Overall accuracy for osteomyelitis detection in severe ulcers was a mere 18.5 percent. The authors argue that these figures quantify the danger of false reassurance: a clinician who relies on a negative ultrasound to exclude bone infection in a severely ulcerated foot risks delayed diagnosis, inadequate surgical debridement, and ultimately amputation.

The picture changes dramatically when the target shifts from bone to soft tissue. For abscess detection, ultrasound achieved perfect sensitivity of 100 percent in both moderate and severe ulcers, meaning a negative scan reliably rules out a drainable collection. Specificity, however, was poor, at 30.4 percent overall and as low as 22.6 percent in severe ulcers, producing a flood of false positives and a positive predictive value of only 46.6 percent overall. The practical implication is that ultrasound works well as a rule-out tool for abscess but should not be used alone to confirm one before committing a patient to surgical drainage. For cellulitis, ultrasound identified the condition in 126 of 127 cases, agreeing with both the clinical diagnosis and MRI in 99.2 percent of participants, although the authors caution that because every participant had clinically diagnosed cellulitis, these concordance figures describe detection rather than true discriminative accuracy.

Why does ultrasound fail so badly at bone? The physics and anatomy offer an explanation. Ultrasound sound waves reflect strongly at soft tissue interfaces and cannot penetrate cortical bone, so the modality can only infer infection from secondary signs at the bone surface, such as periosteal reaction or cortical irregularity. Early marrow infection, which MRI captures through signal changes deep within the bone, produces no visible surface change for the ultrasound probe to detect. The study’s authors also note operator dependence and probe quality as limiting factors, and they contrast their findings with earlier literature: a 1999 study by Enderle and colleagues reported ultrasound sensitivity of 78.6 percent for chronic osteomyelitis, and paediatric studies have shown better performance in acute haematogenous osteomyelitis, where accessible affected areas and different disease biology may favour surface detection.

The study is candid about its limitations. Bone biopsy with histopathology and microbiology remains the definitive gold standard for osteomyelitis, but subjecting every participant to an invasive bone procedure was not ethically justifiable, so MRI served as the reference standard, and MRI itself is imperfect. Charcot neuroarthropathy, with its reactive marrow oedema, can mimic infection on MRI and may have inflated apparent disease in some cases. Each modality was read by a single radiologist, so interobserver reproducibility could not be assessed. Requiring contrast-enhanced MRI excluded patients with advanced kidney disease, a group in whom chronic renal impairment is common and in whom ultrasound may in practice be the only feasible option. Patients with indeterminate MRI bone findings, described as osteitis without confluent marrow replacement, were excluded rather than adjudicated, a recognised source of optimistic bias in diagnostic accuracy studies. The predominance of severe ulcers in the cohort also introduces spectrum bias toward the very patients in whom ultrasound performed worst.

Microbiological data from the cohort add epidemiological texture. Staphylococcus aureus was the most prevalent pathogen at 25.2 percent, followed by Escherichia coli at 18.1 percent, Staphylococcus epidermidis at 14.2 percent, Enterococcus species at 13.4 percent, Pseudomonas aeruginosa at 9.4 percent, Klebsiella pneumoniae at 8.7 percent and Acinetobacter baumannii at 7.9 percent. Most ulcers were severe: 37 percent were Wagner grade 3, 31.5 percent grade 4 and 16.5 percent grade 5, with the forefoot the most commonly involved region at 48 percent and the plantar surface the most frequent site of surface involvement at 40.9 percent. No imaging-related complications were recorded for either modality.

The authors propose a tiered diagnostic protocol as the study’s practical takeaway. Ultrasound, cheap, portable and radiation-free, earns its place as a first-line triage tool for soft-tissue complications, rapidly identifying abscesses that need drainage and confirming cellulitis at the bedside. But its diagnostic ceiling at the bone surface is now quantified, and it is low. Where osteomyelitis is clinically suspected and ultrasound is negative, MRI remains a mandatory next step, consistent with current IWGDF guidance that recommends plain radiography first, followed by MRI when suspicion persists. In a condition where every day of delay narrows the window between debridement and amputation, the message for clinicians is unambiguous: trust ultrasound to map the soft tissues, but never let a negative scan silence suspicion of infection in the bone.

Subject of Research: Diagnostic accuracy of ultrasonography versus MRI for detecting osteomyelitis and soft-tissue infections in diabetic foot ulcers

Article Title: Ultrasonography Cannot Exclude Osteomyelitis in Diabetic Foot Ulcers: A Cross‐Sectional Diagnostic Accuracy Study Against Magnetic Resonance Imaging

Article References: Haghighi‐Morad, M., Vahedi, H., Fard, A. Y., Pordanjani, B. M., & Mahmoudi, S. T. S. (2026). Ultrasonography Cannot Exclude Osteomyelitis in Diabetic Foot Ulcers: A Cross‐Sectional Diagnostic Accuracy Study Against Magnetic Resonance Imaging. Endocrinology, Diabetes & Metabolism, 9(5), Article e70320. https://doi.org/10.1002/edm2.70320

Image Credits: AI Generated

DOI: 10.1002/edm2.70320

Keywords: diabetic foot ulcer, osteomyelitis, ultrasonography, MRI, diagnostic accuracy, amputation, abscess, cellulitis, diabetes complications, medical imaging, Wagner classification, IWGDF guidelines